Wealth Architects »

Silverback Therapeutics shares owned by Wealth Architects

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Wealth Architects from 13F filings

Historical chart of Wealth Architects investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Wealth Architects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Wealth Architects

Quarter filed Position value Share count Share price at filing
2025-12-31 $117k 10k 11.65

More positions owned by Wealth Architects

Ishares Tr Core S&p500 Etf (IVV)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Specialized Funds Div App Etf (VIG)
Lam Research Corp Com New (LRCX)
Spdr Index Shs Fds S&p Gblinf Etf (GII)
Apple (AAPL)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Dimensional Etf Trust Us Large Cap Val (DFLV)

View all positions for Wealth Architects

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
Rubric Capital Management
BlackRock
Sr One Capital Management
Standard Life Aberdeen
Vanguard Group
State Street Corporation
Alliancebernstein
Franklin Resources
UBS Group
Tyro Capital Management
Citadel Advisors
Casdin Capital

View all funds holding Silverback Therapeutics